Business Description
Stryker Corp
NAICS : 339112
SIC : 3841
ISIN : US8636671013
Share Class Description:
SYK: Ordinary SharesTotal Employee Number:
56,000Compare
Compare
Traded in other countries / regions
SYK.USASYK.CanadaS1YK34.Brazil0R2S.UKSYK.MexicoSYK.GermanySYK.Austria1SYK.Italy Index Membership
S&P 500Russell 1000Russell 3000MSCI World Index IPO Date
1979-05-02Description
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.23 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.62 | |||||
Debt-to-EBITDA | 2.13 | |||||
Interest Coverage | 19.43 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 4.9 | |||||
Beneish M-Score | -2.72 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.4 | |||||
3-Year EBITDA Growth Rate | 15 | |||||
3-Year EPS without NRI Growth Rate | 13.4 | |||||
3-Year FCF Growth Rate | 27.7 | |||||
3-Year Book Growth Rate | 10.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 11 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.43 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 35.11 | |||||
9-Day RSI | 41.98 | |||||
14-Day RSI | 46.38 | |||||
3-1 Month Momentum % | 4.35 | |||||
6-1 Month Momentum % | -13.4 | |||||
12-1 Month Momentum % | -16.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.16 | |||||
Quick Ratio | 1.33 | |||||
Cash Ratio | 0.52 | |||||
Days Inventory | 217.08 | |||||
Days Sales Outstanding | 53.44 | |||||
Days Payable | 64.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.05 | |||||
Dividend Payout Ratio | 0.25 | |||||
3-Year Dividend Growth Rate | 6.2 | |||||
Forward Dividend Yield % | 1.06 | |||||
5-Year Yield-on-Cost % | 1.52 | |||||
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | 1.11 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 64.98 | |||||
Operating Margin % | 21.73 | |||||
Net Margin % | 14.43 | |||||
EBITDA Margin % | 27.11 | |||||
FCF Margin % | 18.2 | |||||
OCF Margin % | 21.38 | |||||
ROE % | 16.59 | |||||
ROA % | 7.92 | |||||
ROIC % | 10.41 | |||||
3-Year ROIIC % | 11.97 | |||||
ROC (Joel Greenblatt) % | 68.39 | |||||
ROCE % | 14.46 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 8 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 33.97 | |||||
Forward PE Ratio | 21.82 | |||||
PE Ratio without NRI | 23.5 | |||||
Shiller PE Ratio | 42.97 | |||||
Price-to-Owner-Earnings | 27.39 | |||||
PEG Ratio | 1.67 | |||||
PS Ratio | 4.9 | |||||
PB Ratio | 5.24 | |||||
Price-to-Free-Cash-Flow | 26.94 | |||||
Price-to-Operating-Cash-Flow | 22.93 | |||||
EV-to-EBIT | 23.72 | |||||
EV-to-Forward-EBIT | 28.2 | |||||
EV-to-EBITDA | 19.59 | |||||
EV-to-Forward-EBITDA | 19.42 | |||||
EV-to-Revenue | 5.31 | |||||
EV-to-Forward-Revenue | 5.06 | |||||
EV-to-FCF | 29.18 | |||||
Price-to-GF-Value | 0.79 | |||||
Price-to-Projected-FCF | 1.93 | |||||
Price-to-DCF (Earnings Based) | 1.53 | |||||
Price-to-DCF (FCF Based) | 1.11 | |||||
Price-to-Median-PS-Value | 0.9 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.88 | |||||
Earnings Yield (Greenblatt) % | 4.22 | |||||
FCF Yield % | 3.74 | |||||
Forward Rate of Return (Yacktman) % | 15.02 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:SYK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Stryker Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 25,837 | ||
| EPS (TTM) ($) | 9.65 | ||
| Beta | 0.6364 | ||
| 3-Year Sharpe Ratio | 0.11 | ||
| 3-Year Sortino Ratio | 0.17 | ||
| Volatility % | 20.63 | ||
| 14-Day RSI | 46.38 | ||
| 14-Day ATR ($) | 10.183823 | ||
| 20-Day SMA ($) | 338.635 | ||
| 12-1 Month Momentum % | -16.23 | ||
| 52-Week Range ($) | 281 - 396.86 | ||
| Shares Outstanding (Mil) | 383.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Stryker Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Stryker Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-02-11 | In 170 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-01-29 16:30 | In 158 days | ||
| Fourth quarter earnings results for 2026 | 2027-01-29 | In 157 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-30 16:30 | In 67 days | ||
| Third quarter earnings results for 2026 | 2026-10-30 16:05 | In 67 days | ||
| USD 0.880000 Cash Dividend | 2026-09-30 | In 36 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-30 16:30 | 352.25 (+2.36%) | ||
| Second quarter earnings results for 2026 | 2026-07-30 16:05 | 352.25 (+2.36%) | ||
| USD 0.880000 Cash Dividend | 2026-06-30 | 330.52 (-0.77%) | ||
| Guidance call for 2026 | 2026-05-13 13:40 | 294.45 (+3.03%) |
Show
Entries
Stryker Corp Frequently Asked Questions
What is Stryker Corp(SYK)'s stock price today?
The current price of SYK is $327.81. The 52 week high of SYK is $396.86 and 52 week low is $281.00.
When is next earnings date of Stryker Corp(SYK)?
The next earnings date of Stryker Corp(SYK) is 2026-10-30 Est..
Does Stryker Corp(SYK) pay dividends? If so, how much?
The Dividend Yield %  of Stryker Corp(SYK) is 1.05% (As of Today), Highest Dividend Payout Ratio of Stryker Corp(SYK) was 0.32. The lowest was 0.25. And the median was 0.27. The  Forward Dividend Yield % of Stryker Corp(SYK) is 1.06%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on NYSE:SYK
Nzs Capital Growth
Bullish
2026 Q1
What the manager wrote
Stryker, which had been on our watchlist as a strong fit for our framework, was added as a new resilient position after the valuation became more attractive. Healthcare has increased in weight in the portfolio in recent quarters as fundamentals have normalized after a long post-COVID hangover, and valuations have become less demanding. Increasing lifespans from GLP-1 adoption may provide tailwinds for several segments of the healthcare sector.
Parnassus Value Equity Fund
Bullish
2025 Q3
What the manager wrote
Stryker offers exposure to a high-quality, defensive compounder. While shares have underperformed recently, the company's durable growth runway is supported by a slate of new launches in its MedSurg business segment and expanding adoption of its robotics surgery platform in orthopedic procedures. We also expect continued progress on profitability under current CEO Kevin Lobo, who has a strong track record of leading successful innovations.
Press Release
Articles on Stryker Corp
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers